ASH 2018: updated results on IPH4102 and KOL webcast
A KOL webcast and conference call was held on Tuesday, December 4, at 5pm CET (8am PST)
Welcome to Innate Pharma
Scroll
About Innate Pharma
Innate Pharma S.A. is a fully integrated oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Headlines
Innate Pharma announces publication of monalizumab research in the prestigious “Cell” journal widening the horizon of immune checkpoint inhibitors
Published in the prestigious journal Cell on November 29, 2018 , this work will now be used as a reference for later development of monalizumab.
Innate Pharma strengthens and expands its oncology development collaboration with AstraZeneca
Conference call for analysts and investors to discuss this announcement.